Frontiers | Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
Resources for CD 19 | Biomarker for normal and neplastic B cell | OriGene
CD antigens expression in B cells | Sino Biological
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library
Modulation of CD19 promoter activity in cHL and B-NHL cell lines. (A)... | Download Scientific Diagram
What Is CD19 Antigen? – Creative Biolabs CAR-T Blog
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
What Is CD19 Antigen? – Creative Biolabs CAR-T Blog
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases | SpringerLink
B Cell Overview | Thermo Fisher Scientific - US
Molecular analysis of a CD19-negative diffuse large B-cell lymphoma | Haematologica
Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model
B Cell Overview | Thermo Fisher Scientific - US
CD19：a validated therapeutic target for B-cell malignancies - ACROBiosystems
T Cell Markers and B Cell Markers
CD19 - The Marker, the Antibodies | Bio-Rad
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Antigen-experienced CXCR5- CD19low B cells are plasmablast precursors expanded in SLE | medRxiv
Unraveling B cell trajectories at single cell resolution: Trends in Immunology
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
Standing out from the crowd: How to identify plasma cells
B-cell development and expression of surface markers targeted by... | Download Scientific Diagram
Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer
Memory B Cell Markers: R&D Systems
